Original Article
Free Access
Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys
Károly Lapis,
József Bocsi,
Péter Lapis MD,
Unnur P. Thorgeirsson,
Károly Lapis
First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, Hungary
Search for more papers by this authorJózsef Bocsi
First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, Hungary
Search for more papers by this authorCorresponding Author
Péter Lapis MD
Memorial Hospital of Rhode Island, Department of Pathology, Brown University, School of Medicine, Pawtucket, RI
Professor of Pathology, First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest VIII. Üllöi út 26, Hungary, H-1085===Search for more papers by this authorUnnur P. Thorgeirsson
Division of Cancer Etiology, National Cancer Institute, Bethesda, MD
Search for more papers by this authorKároly Lapis,
József Bocsi,
Péter Lapis MD,
Unnur P. Thorgeirsson,
Károly Lapis
First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, Hungary
Search for more papers by this authorJózsef Bocsi
First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, Hungary
Search for more papers by this authorCorresponding Author
Péter Lapis MD
Memorial Hospital of Rhode Island, Department of Pathology, Brown University, School of Medicine, Pawtucket, RI
Professor of Pathology, First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest VIII. Üllöi út 26, Hungary, H-1085===Search for more papers by this authorUnnur P. Thorgeirsson
Division of Cancer Etiology, National Cancer Institute, Bethesda, MD
Search for more papers by this authorAbstract
Flow cytometric DNA analysis was carried out on diethylnitrosamine (DEN) induced primary hepatocellular carcinomas (HCC) and lung metastases in monkeys. In analyzing one sample from each of 113 HCC cases, 76 (67.2%) were diploid and 37 (32.7%) aneuploid. When more samples were analyzed from the same tumorous liver, all of the 76 diploid cases maintained their pattern, whereas 5 (13.5%) of the aneuploid cases displayed both diploid and aneuploid DNA. Studies of lung metastases from 44 (28 diploid, 16 aneuploid) HCC cases showed that the DNA-ploidy pattern characterizing the primary HCC was preserved in the metastases in 78.6% of the diploid and 93.7% of the aneuploid cases. The average synthetic phase fraction (SPF) value for the diploid tumors was 7.7% and the aneuploid tumors 14.9%. The difference is highly significant (P < .01). Highly significant correlation was found between the DNA ploidy and the SPF values, both in the primary HCC (P = .0001) and the metastases (P = .0266). Of different tumor and host features examined, statistically significant correlation was only found between DNA-ploidy/SPF and the cytological tumor grade. This study represents the first DNA-ploidy analysis of HCC in monkeys. The data showed that diploid and aneuploid tumors displayed comparable metastatic potential. The DNA-ploidy pattern was preserved in the metastases in the majority of the cases. (Hepatology 1995; 22:952–961.)
References
- 1 Barlogie B, Drewinko B, Schumann J. Cellular DNA content as a marker of neoplasia in man. Am J Med 1980; 69: 195–203.
- 2 Atkin NB, Kay R. Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases. Br J Cancer 1979; 40: 210–221.
- 3 Rim KS, Sakamoto M, Watanabe H, Matsuno Y, Nakanishi Y, Mukai K, Hirohashi S. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in nodule appearance: evidence for stepwise progression of hepatocellular carcinoma. Jpn J Clin Oncol 1993; 23: 26–33.
- 4 Petrakis NL. Microspectrophotometric estimation of deoxyribonucleic-acid (DNA) content of individual normal and leukaemic human lymphocytes. Blood 1953; 8: 905–915.
- 5 Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23–29.
- 6 Frankfurt OS, Arbuck SG, Chin JL, Greco WR, Pavelic ZP, Slocum HK, Mittelman A, et al. Prognostic application of DNA flow cytometry for human solid tumors. Ann NY Acad Sci 1986; 468: 276–290.
- 7 Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol 1984; 37: 961–974.
- 8 Merkel DE, Dressler LG, McGuire WL. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol 1987; 5: 1690–1703.
- 9 Andreef M, Assing G, Cirrincione C. Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multi-variate analysis. In: Andreoff M, ed. Clinical cytometry. Ann N Y Acad Sci 1986; 468: 387–406.
- 10 Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber PE, Göhde W, et al. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982–3997.
- 11 Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ. Prognostic significance DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 1990; 45: 34–39.
- 12 Douglas EM, Dressler LG, McGuire WL. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol 1987; 5: 1690–1703.
- 13
Kallioniemi O,
Punnonen R,
Mattila J,
Lehtinen M,
Koivula T.
Prognostic significance of DNA index, multiploidy, and S-phase fraction.
Cancer
1988;
61:
334–339.
10.1002/1097-0142(19880115)61:2<334::AID-CNCR2820610224>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 14
Merkel DE,
McGuire W.
Ploidy, proliferative activity and prognosis.
Cancer
1990;
65:
1194–1205.
10.1002/1097-0142(19900301)65:5<1194::AID-CNCR2820650528>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 15 Raber MN, Barlogie B. DNA flow cytometry of human solid tumors. In: MR Melamed, T Lindmo, ML Mendelsohn, eds. Flow cytometry and sorting. New York; Wiley, 1990: 745–754.
- 16
Dressler LG,
Seamer LC,
Owens MA,
Clark GM,
McGuire WL.
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Cancer
1988;
61:
420–427.
10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- 17
Asanuma H,
Nakajima T,
Mukai K,
Noguchi M,
Shimosato Y.
DNA cytofluorometric and nuclear morphometric analyses of lung carcinoma.
Cancer
1989;
64:
1657–1664.
10.1002/1097-0142(19891015)64:8<1657::AID-CNCR2820640817>3.0.CO;2-4 PubMed Web of Science® Google Scholar
- 18
Giaretti W,
Danova M,
Geido E,
Mazzini G,
Sciallero S,
Aste H,
Scivetti P, et al.
Flow cytometric DNA index in the prognosis of colorectal cancer.
Cancer
1991;
67:
1921–1927.
10.1002/1097-0142(19910401)67:7<1921::AID-CNCR2820670717>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- 19
De Kernion JB,
Mukamel E,
Ritchie AW,
Blyth B,
Hannah J,
Bohman R.
Prognostic significance of the DNA content of renal carcinoma.
Cancer
1989;
64:
1669–1673.
10.1002/1097-0142(19891015)64:8<1669::AID-CNCR2820640819>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 20 McEntee GP, Batts KA, Katzmann JA, Ilstrup DM, Nagorney DM. Relationship of nuclear DNA content tc clinical and pathologic findings in patients with primary hepatic malignancy. Surgery 1992; 111: 376–379.
- 21 Nagasue N, Yamanoi A, Takemoto Y, Kimoto T, Uchida M, Chang Y-C, Taniura H, et al. Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study. Br J Surg 1992; 79: 667–670.
- 22
Ezaki T,
Kanematsu T,
Okamura T,
Sonoda T,
Sugimachi K.
DNA analysis of hepatocellular carcinoma and clinicopathologic implications.
Cancer
1988;
61:
106–109.
10.1002/1097-0142(19880101)61:1<106::AID-CNCR2820610118>3.0.CO;2-R PubMed Web of Science® Google Scholar
- 23 Chen MF, Hwang TL, Tsao KC, Sun CF, Chen TJ. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report. Surgery 1991; 109: 455–458.
- 24
Fujimoto J,
Okamoto E,
Yamanaka N,
Toyosaka A,
Mitsunobu M.
Flow cytometric DNA analysis of hepatocellular carcinoma.
Cancer
1991;
67:
939–944.
10.1002/1097-0142(19910215)67:4<939::AID-CNCR2820670414>3.0.CO;2-J PubMed Web of Science® Google Scholar
- 25 Chiu JH, Kao HL, Wu LH, Chang HM, Lui WY. Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J Clin Invest 1992; 89: 539–545.
- 26 Ng IOL, Lai ECS, Ho JCW, Cheung LKN, Ng MMT, So MKP. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am J Clin Pathol 1994; 102: 80–86.
- 27 Scott RJ, Chakraborty S, Sell S, Hunt JM, Dunsford HA. Change in the ploidy state of rat liver cells during chemical hepatocarci-nogenesis and its relationship to the increased expression of alfafetoprotein. Cancer Res 1989; 49: 6085–6090.
- 28 Inui N, Takayama S, Kuwabara N. DNA measurement on cell nucleus of normal liver, adenoma, and hepatoma in mice: histologic features. J Natl Cancer Inst 1971; 47: 47–58.
- 29 Zerban H, Rabes HM, Bannasch P. Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis. J Cancer Res Clin Oncol 1989; 115: 329–334.
- 30 Gerlyng P, Grotmol T, Erikstein B, Stokke T, Seglen PO. Reduced proliferative activity of polyploid cells in primary hepatocellular carcinoma. Carcinogenesis 1992; 13: 1795–1801.
- 31 Thorgeirsson UP, Dalgard DW, Reeves J, Adamson RH. Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regul Toxicol Pharmacol 1994; 19: 130–151.
- 32 Gibson JB, Sobin LH. Histological typing of tumours of the liver, biliary tract and pancreas. International Histological Classification of Tumours. No. 20. Geneva: World Health Organization, 1978.
- 33 Heiden T, Wang N, Tribukait B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 1991; 12: 614–621.
- 34 Babiak J, Poppema S. Automated procedure for dewaxing and rehydration of paraffin embedded tissue section for DNA flow cytometric analysis of breast tumors. Am J Clin Pathol 1991; 96: 64–69.
- 35 Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–1335.
- 36 Kallioniemi O, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T. Aneuploid DNA content and S-phase fraction of tumour cell are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 1987; 23: 277–282.
- 37 Giaretti W. Ploidy and proliferation evaluated by flow cytometry: an overview of techniques and impact in oncology. Tumori 1991; 77: 403–419.
- 38 Coon JS, Landay AL, Weinstein RS. Advances in flow cytometry for diagnostic pathology. Lab Invest 1987; 57: 453–479.
- 39 Rabinovitch PS. Multiple option cell cycle analysis. Multicycle, 1–16. Becton-Dickinson, San Jose, CA.
- 40 Hiddemann W, Schumann J, Andreeff M. Convention of nomenclature for DNA cytometry. Cytometry 1984; 5: 445–446.
- 41 Biomedical Data Processing. Berkeley: University Press California, 1990.
- 42 Koike Y, Suzuki Y, Nagata A, Furuta S, Nagata T. Studies on DNA content of hepatocytes in cirrhosis and hepatoma by means of microspectrophotometry and radioautography. Histochemistry 1982; 73: 549–562.
- 43 Kuo SH, Sheu JC, Chen DS, Sung JL, Lin CC, Hsu HC. DNA clonal heterogeneity of hepatocellular carcinoma demonstrated by Feulgen-DNA analysis. Liver 1987; 7: 359–363.
- 44 Saeter G, Lee CZ, Schwarze PE, Ous S, Chen D-S, Sung J-L, Seglen PO. Changes in ploidy distributions in human liver carci-nogenesis. J Natl Cancer Inst 1988; 80: 1480–1485.
- 45
Yoshida Y,
Okamura T,
Kanematsu T,
Kakizoe S,
Sugimachi K.
Comparison between microspectrophotometry and cytofluorometry in measurements of nuclear DNA in human hepatocellular carcinomas.
Cancer
1988;
62:
755–759.
10.1002/1097-0142(19880815)62:4<755::AID-CNCR2820620419>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 46 Ishizu H. Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma. Jpn J Surg 1989; 19: 662–673.
- 47
Cong WM,
Wu MC.
The biopathologic characteristics of DNA content of hepatocellular carcinomas.
Cancer
1990;
66:
498–501.
10.1002/1097-0142(19900801)66:3<498::AID-CNCR2820660316>3.0.CO;2-2 CAS PubMed Web of Science® Google Scholar
- 48 Lin HH, Shyu WC, Chen GL, Lin YH, Chen TJ, Liaw YF. DNA measurements in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Liver 1990; 10: 313–318.
- 49 Chen PJ, Chen DS, Lai MY, Chang MH, Huang GT, Yang PM, Sheu JC, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989; 96: 527–529.
- 50 Kopper L, Lapis K, Schaff ZS, Mihalik R, Karácsony S, Szécsény A. Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma. Neoplasma 1991; 38: 257–263.
- 51 Nagasue N, Kohno H, Chang YC, Yamanoi A, Kimoto T, Takemoto Y, Nakamura T. DNA ploidy pattern in synchronous and metachronous hepatocellular carcinomas. J Hepatol 1992; 16: 208–214.
- 52 Deprez C, Vangansbeke D, Fastrez R, Pasteels J-L, Verhest A, Kiss R. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Am J Clin Pathol 1993; 99: 558–565.
- 53 Kopper L, Lapis K, Schaff ZS, Mihalik R. Significance of cellular DNA content in human liver tumors. Acta Biomedica de “L'Ateneo Parmense” 1993; 64: 165–169.
- 54 Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, Makino Y, et al. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology 1993; 105: 1449–1454.
- 55
Noguchi S,
Yamamoto R,
Tatsuta M,
Kasugai H,
Okuda S,
Wada A,
Tamura H.
Cell features and patterns in fine-needle aspirates of hepatocellular carcinoma.
Cancer
1986;
58:
321–328.
10.1002/1097-0142(19860715)58:2<321::AID-CNCR2820580219>3.0.CO;2-B PubMed Web of Science® Google Scholar
- 56 Roncalli M, Borzio M, Brando B, Colloredo G, Servida E. Abnormal DNA content in liver-cell dysplasia: a flow cytometric study. Int J Cancer 1989; 44: 204–207.
- 57 Taper HS, Bannasch P. Histochemical differences between socalled megalocytosis and neoplastic or preneoplastic liver lesions induced by N-Nitrosomorpholine. Eur J Cancer 1979; 15: 189–196.
- 58 Mori H, Tanaka T, Sugie S, Takahashi M, Williams GM. DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J Natl Cancer Inst 1982; 69: 1277–1281.
- 59 Digernes V. Chemical liver carcinogenesis: monitoring of the process by flow cytometric DNA measurements. Environ Health Perspect 1983; 50: 195–200.
- 60 Tsao MS, Grisham JW, Nelson KG, Smith JD. Phenotypic and karyotypic changes induced in cultured rat hepatic epithelial cells that express the “oval” cell phenotype by exposure to N-Methyl-N,-nitro-N-nitrosoguanidine. Am J Pathol 1985; 118: 306–315.
- 61 Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu YH, Sargent L, et al. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 1989; 17: 594–611.
- 62 Sudilovsky O, Hei TK. Aneuploidy and progression in promoted preneoplastic foci during chemical hepatocarcinogenesis in the rat. Cancer Lett 1991; 56: 131–135.
- 63 Hirohashi S. Pathology and molecular mechanisms of multistage human hepatocarcinogenesis. Princess Takamatsu Symp 1991; 22: 87–93.
- 64 Sudilovsky O, Hinrichsen LI, Hei TK, Whitacre CM, Wang JH, Kasturi S, Jiang SH, et al. Genetic instability occurs sooner than expected: promotion, progression and clonality during hepatocarcinogenesis in the rat. Basic Life Sci 1991; 57: 263–277.
- 65 Pitot HC. Characterization of the stage of progression in hepatocarcinogenesis in the rat. Basic Life Sci 1991; 57: 3–18.
- 66 Faktor VM, Eliseeva NA, Tamakhina Ala. The effect of the alkylating carcinogen dipin on the proliferation, the level of polyploidy development and on micronucleus formation in a population of parent and newly formed hepatocytes. Izv Akad Nauk Serb Biol 1992: 821–834.
- 67 Onodera K, Ebata H, Kasai S, Mito M. A study of progression in hepatocarcinogenesis using cell transplantation system. Nippon-Geka Gakkai Zasshi 1992; 93: 932–936.
- 68 Cong WM, Wu MC, Zhang XZ. Characteristic changes of DNA stemlines during hepatocarcinogenesis in rats. Chin Med J (Engl) 1992; 105: 535–538.
- 69 Cong WM. Characteristics and biologic significance of changes in DNA content of rat liver cells during hepatocarcinogenesis. Chung Hua Chung Liu Tsa Chih 1992; 14: 20–23.
- 70 Sato A, Higashi T, Ling L, Shiota T, Tsuji T. Rat liver nodules induced by 2-acetyl-aminofluorene lose an ability to take up indocyanine green in the process of hepatocarcinogenesis. Acta Med Okayama 1992; 46: 57–66.
- 71 Dragan YP, Sargent L, Xu YD, Xu YH, Pitot HC. The initiation promotion progression model of rat hepatocarcinogenesis. Proc Soc Exp Biol Med 1993; 202: 16–24.
- 72 Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, et al. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Hepatology 1994; 19: 389–397.
- 73 Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994; 19: 810–819.
- 74 Styles J, Elliot BM, Lefevre PA, Robinson M, Pritchard N, Hart D, Ashby J. Irreversible depression in the ration of tetraploid: diploid liver nuclei in rats treated with 3,-methyl-4-dimethylami-noazobenzene (3,M). Carcinogenesis (Lond.) 1985; 6: 21–28.
- 75 Schwarze PE, Pettersen EO, Shoaib MC, Seglen PO. Emergence of a population of small, diploid hepetocytes during hepatocarci-nogenesis. Carcinogenesis (Lond.) 1984; 5: 1267–1275.
- 76 Schwarze PE, Saeter G, Armstrong D, Cameron RG, Laconi E, Sarma DS, Preat V, et al. Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments. Carcinogenesis 1991; 12: 325–327.
- 77 Digernes V, Elgjo K. Dimethyl nitrosamine-induced proliferative and neoplastic lesions in the mouse liver characterized by histopathology and flow cytometric DNA measurements. Acta Pathol Microbiol Immunol Scand (A) 1984; 92: 45–53.
- 78
Seglen PO,
Schwarze PE,
Saeter G.
Nuclear alterations in liver carcinogenesis: the role of nonpolyploidizing growth. In:
F Feo,
P Pani,
R Garcea, eds.
Chemical carcinogenesis models and mechanisms.
New York:
Plenum Press,
1988:
435–445.
10.1007/978-1-4757-9640-7_48 Google Scholar
- 79 Jack EM, Bentley P, Bieri F, Muakkassah-Kelly SF, Stäubli W, Suter J, Waechter F, et al. Increase in hepatocyte and nuclear volume and decrease in the population of binucleated cells in preneoplastic foci of rat liver: a stereological study using the nucleator method. Hepatology 1990; 11: 286–297.
- 80 Sarafoff M, Rabes HM, Dörmer P. Correlation between ploidy and initiation probability determined by DNA cytophotometry in individual altered hepatic foci. Carcinogenesis 1986; 7: 1191.
- 81 Yoshida Y, Kanematsu T, Korenaga D, Sonoda T, Sugimachi K. DNA ploidy of primary hepatocellular carcinoma and pulmonary metastases. Clin Exp Metastasis 1992; 10: 337–344.
- 82
Okita K,
Noda K,
Numa Y,
Ando K.
A significance of hyperplastic liver nodules as the precancerous lesion analyzed from the view point of cell growth.
Kanzo
1981;
22:
559–564 (in Japanese).
10.2957/kanzo.22.559 Google Scholar
- 83
Henmi A.
Karyometric analysis of nuclear atypism in hepatocellular tumors and tumor-like lesions.
Kanzo
1983;
24:
1367–1373 (in Japanese).
10.2957/kanzo.24.1367 Google Scholar
- 84 Schnipper LE. Clinical implications of tumor cell heterogeneity. N Engl J Med 1986; 314: 1423–1431.
- 85 Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985; 6: 327–333.
- 86 Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Prediction of relapse or survival in patients with nodenegative breast cancer by DNA flow cytometry. N Engl J Med 1989; 320: 627–633.
- 87 Kuo SH, Sheu JC, Chen DS, Sung JL, Lin CC, Hsu HC. Cytophotometric measurements of nuclear DNA content in hepatocellular carcinoma. Hepatology 1987; 7: 330–332.
- 88 Lapis K, Sarosi I, Bocsi J, Thorgeirsson UP. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys. Lab Invest 1995; 72: 748–759.
